loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of Micafungin reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Micafungin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 103,536Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Funguard

    02 6Funguard/Mycamine

    03 1Mycamine

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Funguard/Mycamine

    Micafungin Sodium

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Funguard/Mycamine

    Japan
    arrow
    Luxepack
    Not Confirmed

    Astellas

    Micafungin Sodium

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 257

    2019 Revenue in Millions : 322

    Growth (%) : -20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Funguard/Mycamine

    Micafungin Sodium

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Funguard/Mycamine

    Japan
    arrow
    Discovery on Target
    Not Confirmed

    Astellas

    Micafungin Sodium

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 15

    2020 Revenue in Millions : 255

    Growth (%) : -94

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Funguard

    Micafungin Sodium

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Funguard

    Japan
    arrow
    Discovery on Target
    Not Confirmed

    Astellas

    Micafungin Sodium

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 9

    2021 Revenue in Millions : 14

    Growth (%) : -32

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Mycamine

    Micafungin Sodium

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Mycamine

    Japan
    arrow
    Discovery on Target
    Not Confirmed

    Astellas

    Micafungin Sodium

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 107

    2021 Revenue in Millions : 116

    Growth (%) : -8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Funguard/Mycamine

    Micafungin Sodium

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Funguard/Mycamine

    Japan
    arrow
    Discovery on Target
    Not Confirmed

    Astellas

    Micafungin Sodium

    Main Therapeutic Indication : Anti-Fungal

    Currency : USD

    2018 Revenue in Millions : 325

    2017 Revenue in Millions : 307

    Growth (%) : 6%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Funguard/Mycamine

    Micafungin sodium

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Funguard/Mycamine

    Japan
    arrow
    Discovery on Target
    Not Confirmed

    Astellas

    Micafungin sodium

    Main Therapeutic Indication : Anti-fungal

    Currency : USD

    2016 Revenue in Millions : 363

    2015 Revenue in Millions : 369

    Growth (%) : -2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Funguard/Mycamine

    Micafungin Sodium

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Funguard/Mycamine

    Japan
    arrow
    Discovery on Target
    Not Confirmed

    Astellas

    Micafungin Sodium

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2019 Revenue in Millions : 326

    2018 Revenue in Millions : 336

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Funguard/Mycamine

    Micafungin Sodium

    arrow
    Discovery on Target
    Not Confirmed

    Brand Name : Funguard/Mycamine

    Japan
    arrow
    Discovery on Target
    Not Confirmed

    Astellas Pharma

    Micafungin Sodium

    Main Therapeutic Indication : Anti-fungal

    Currency : USD

    2017 Revenue in Millions : 327

    2016 Revenue in Millions : 387

    Growth (%) : -15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF